Fairvalue-Calculator Fairvalue-Calculator
EN DE

S&S Healthcare Holding (4198) Fair Value & Analysis

Healthcare · TW · Market cap 892M TWD

Price38.50 TWD
Fair Value42.28 TWD
Upside+9.8%
Quality80/100
Evidence: Low Range 31.71 TWD – 52.85 TWD

Fair value as of: Jun 24, 2026

Analysis

S&S Healthcare Holding (4198) currently trades at 38.50 TWD, while our model-based Fair Value estimate is 42.28 TWD — implying the stock looks roughly 9.8% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sales of medical imaging devices in Taiwan, the United States, Switzerland, and internationally. It develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd. and changed its name to S&S Healthcare Holding Ltd. in August 2020. S&S Healthcare Holding Ltd. was founded in 1988 and is headquartered in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is S&S Healthcare Holding (4198) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 42.28 TWD versus a price of 38.50 TWD — about +10% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 4198?
Our 21-model fair value for S&S Healthcare Holding is 42.28 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 38.50 TWD.
What is the quality score of 4198?
S&S Healthcare Holding has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.